Biocomposites wins two Queen’s Awards for Enterprise in Innovation and International Trade
Innovation award recognises STIMULAN Rapid Cure as the only calcium sulfate antibiotic carrier approved for use in bone and soft tissue
International Trade award recognises Biocomposites’ outstanding continuous growth in overseas sales
Keele, UK, 21 April 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is delighted to have been honoured with two Queen’s Awards for Enterprise for Innovation and International Trade.
